the Association of Intestinal Microbial Metabolites and Cardiac Function in Acute Myocardial Infarction

NCT04955054 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-07-08

No results posted yet for this study

Summary

Recently, more and more studies have confirmed that intestinal flora is closely related to the occurrence and development of cardiovascular diseases.Bile acids (BAS), short chain fatty acids (SCFA) and trimethylamine oxide (TMAO), the main metabolites of intestinal flora, are the key mediators of the interaction between gut and host. We aim to explore the association of BAs and SCFA with cardiac function in patients with AMI.

Conditions

  • Acute Myocardial Infarction

Interventions

DIAGNOSTIC_TEST

diagnose

Patients from UAP and AMI meet the criteria of UAP or STEMI.

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-11
Primary Completion
2025-10-11
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04955054 on ClinicalTrials.gov